Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopenia

Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopenia




Source link

One thought on “Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopenia

Leave a Reply

Your email address will not be published. Required fields are marked *